Detalhe da pesquisa
1.
Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain.
Mol Ther
; 32(2): 503-526, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38155568
2.
Optimization of anti-CD19 CAR T cell production for treatment of patients with chronic lymphocytic leukemia.
Mol Ther Methods Clin Dev
; 32(1): 101212, 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38455264
3.
Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trial.
Blood Adv
; 8(3): 802-814, 2024 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37939262